Your plan doesnt cover the drug
Quick Answer: Retatrutide has no current US price because it isnt FDA approved as of May 2026 Tirzepatide pen prices when introduced: Mounjaro (T2D label): ,069.08 per month list Zepbound (obesity label): ,059.87 per month list Lilly priced both tirzepatide formulations to undercut Wegovy (semaglutide 2.4 mg at ,349 list) by about 20 percent
The most common are mild nausea, bloating, or fatigue early on, but these often fade as your body adjusts
6 On average, men are two-times more likely than women to suffer a first acute myocardial infarction, and the incidence is steadily increasing across Canada
As The New Yorker has observed, the rise of GLP-1s marks a shift not only in medicine but in cultureas appetite-modulating drugs move from treating diabetes toward shaping body ideals, identity, and social aspiration
The problem is the drugs are often unaffordable without insurance